Manganese (Mn) is an industrial neurotoxicant in humans and animal models limited to rodent species. The present study analyses the potential neurotoxicity of acute Mn administration in young chicks. The acute (24 h) LD 50 values of Mn following intraperitoneal, intramuscular, subcutaneous and oral administrations of MnCl 2 in seven-day-old chicks were 21.3 mg kg -1 , 28.1 mg kg -1 , 28.1 mg kg -1 and 469.5 mg kg -1 body weight of Mn, respectively. Signs of Mn poisoning appeared in the chicks within 2 min and 13 min after parenteral administration and within 20 min and 32 min after oral administration. The signs demonstrated the depressant action of Mn in the chicks. The behavioural effects of Mn given at 5 mg kg -1 , 10 mg kg -1 and 20 mg kg -1 intramuscularly were examined in 7 to 12 day old chicks using the three-minute open-fi eld and tonic immobility tests. Manganese decreased the overall locomotor activity of the chicks in the open-fi eld arena as manifested by a signifi cant increase in the latency to move from the central square and decreases in line crossing, frequency of defecation and vocalization score when compared to control values. It also increased the duration of the chicks' tonic immobility response. Pharmacological challenges of Mn-treated chicks with general anaesthetics xylazine-ketamine and thiopental caused the loss of right refl ex at a faster rate in comparison with control values. Thiopental increased the duration of loss of righting refl ex in Mn-treated chicks when compared with that of the control group. Chlorpromazine challenge of Mn-treated chicks signifi cantly increased the depressant action of Mn in the open-fi eld arena and increased the duration of tonic immobility response produced by the metal. The injections of Mn at 10 mg kg -1 , 20 mg kg -1 , 50 mg kg -1 and 100 mg kg -1 intramuscularly signifi cantly increased the Mn levels in the plasma, liver, kidneys and entire brain of the chicks. The data suggests acute neurotoxicity of Mn chloride in the young chicks as a form of depressant action that could be determined by open-fi eld and tonic immobility tests with further support from pharmacological challenges.
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Manganese (Mn) is an essential metal considered to be a neurotoxicant at high exposure levels in humans (1) and experimentally in rodents (2) (3) (4) . It is also an occupational neurotoxicant (1) . In humans, toxic levels of Mn produce behavioural changes such as nervousness, hallucination, loss of memory and cognitive abnormalities as well as a Parkinson-like syndrome characterized by weakness, tremor, abnormal posture, rigidity, excessive salivation and speech disorders (1, 5) .
Mice and rats are common laboratory animal models used to assess the various effects of overexposure to Mn (2) (3) (4) . Manganese induces hypoactivity in mice (2) and hyperactivity (3) or hypoactivity (4) in rats.
Studies on the toxicity of Mn in the avian species are rather limited. In one-month old chickens, acute Mn administration at 40 mg kg -1 given subcutaneously (s.c.) reduced jumping attempts in the open-fi eld behavioural paradigm, increased the duration of tonic immobility, while at 50 mg kg -1 s.c, increased the depressant effect of xylazine-ketamine anaesthesia (6) . The nutritional role of Mn in feeding poultry is well-documented (7). However, no published information is available on the toxic effects of Mn in younger chicks (8) . Early postnatal manganese acetate exposure (50 mg kg -1 ) modifi es the neurobehavioural development of herring gull chicks (9) .
The mechanisms of Mn neurotoxicosis and behavioural effects might be related to disturbances of neuronal cells depolarization, blocking calcium channels with catecholamine (10, 11) , as well as excitatory and inhibitory amino acids (12) . In a rat model of Mn intoxication, dopamine D2 receptors were found to be linked to the inhibitory control of glutamatergic (excitatory) corticostriatal transmission (13) . Manganese decreases dopamine, increases homovanilic acid (11) , and decreases GABA (14) concentrations in different regions of the brain of laboratory animals. It also alters the glutamate metabolism by attenuating astrocytic glutamate uptake (15) and inhibits NMDA receptors, subsequently causing a defi ciency of glutamatergic transmission (16) . The neurotoxic effects of Mn could also be the result of oxidative stress to the nervous tissue (17) . The neurochemical and neurobehavioural changes induced by Mn might result from the differential uptake of the metal by various brain regions (18, 19) . The diagnostic or biomarker endpoint of Mn exposure includes determination of plasma and tissue levels of the metal (20, 21) .
The present study aimed to examine the potential acute neurotoxicity of Mn in the 7 day to 14 day old chicks by using a set of neurobehavioural tests and pharmacological challenges. We hypothesized that Mn administration results in the accumulation of the metal in the brain which may subsequently cause alterations in the behavioural response of the chicks.
MATERIALS AND METHODS
One-day-old broiler chicks of both sexes obtained from a commercial hatchery in Mosul, Iraq were housed under constant light at a temperature of 32 °C to 35 °C. Water and commercial poultry feed were available ad libitum and wood shavings were used as fl oor litter. We performed our experiments on the chicks when they turned seven days old (60 g to 85 g body weight). The Scientifi c Committee of the College of Veterinary Medicine at the University of Mosul reviewed and approved the study protocol. All the experiments complied with University regulations addressing the humane and proper use of laboratory animals in experimental studies. All experiments were conducted between 9 and 12 AM. The injectable solution of Mn was prepared by dissolving manganese chloride (MnCl 2 .4H 2 O, Avishkar, India) in deionized distilled water, and all doses were based on the amount of the ionic Mn in the administration volume which was given intramuscularly (i.m.) at 5 mL kg -1 .
Acute toxicity of Mn
We fi rst determined the acute (24-hour) median lethal dose (LD 50 ) of Mn given orally, s.c., i.m. or intraperitoneally (i.p.) using the up-and-down method (22) . We observed each chick for the appearance of any sign of toxicosis for one hour and then recorded the 24-hour lethality. For the LD 50 experiments, we used only five to ten chicks for each route of administration group. The LD 50 s of Mn were determined so that they could be used in subsequent experiments.
Effect of Mn on open-fi eld activity and tonic immobility
Thirty two chicks were randomly divided into four groups of eight birds each. The chicks were injected with either saline solution at 5 mL kg -1 or with Mn at (5, 10, or 20) mg kg -1 i.m. The doses of Mn were chosen after preliminary experiments on chicks in which these doses did not produce obvious signs of poisoning within one hour after treatment. Thirty minutes after the injection of saline or Mn, the chicks were examined during three-minute open-fi eld activity as described before (23) . After the open-fi eld activity test, each chick was used for the tonic immobility behavioural paradigm (23) .
Pharmacological challenges of chicks treated with Mn Anaesthetic challenge
Eight chicks in each group were treated with saline solution at 5 mL kg -1 body weight (control) or with manganese at 10 mg kg -1 body weight, i.m. Fifteen minutes after saline or Mn administration, each chick was injected i.m. with the anaesthetic mixture of xylazine (2 % solution, Alfasan, The Netherlands) 5 mg kg -1 and ketamine (5 % solution, Trittau, Germany) 20 mg kg -1 or thiopental sodium (Bodene, South Africa) at 30 mg kg -1 , i.p. (6, 24) . The latency to the onset of righting refl ex loss after positioning the chick on its side and the duration of loss of righting refl ex were recorded.
Chlorpromazine Challenge
Eight chicks in each group were treated with saline solution at 5 mL kg -1 body weight (control) or with manganese at 10 mg kg -1 body weight, i.m. Thirty minutes following the saline or Mn administration, each chick was injected i.m. with chlorpromazine (NDA, Mosul, Iraq) at 5 mg kg -1 , i.m. (24) . Thirty minutes post chlorpromazine injection, we subjected the chicks to the three-minute open-fi eld behavioural test and tonic immobility behavioural paradigm as mentioned before.
Determination of Mn in the plasma and tissues
Chicks were injected with either saline solution at 5 mL kg -1 i.m. (control group, n=12) or with Mn (6 per group) at (10, 20, 50 and 100) mg kg -1 i.m. Thirty minutes later, the blood was obtained from the jugular vein and then the chicks were sacrifi ced by dislocating the neck to obtain the brain, liver and kidneys. Blood samples were collected into heparinized test tubes and centrifuged at 3000 rpm for 15 min to obtain the plasma. The plasma and tissue samples were placed in suitable volumes of 65 % nitric acid for digestion (25) . The concentration of Mn was determined using an atomic absorption spectrometer (Novaa 350, Germany) supplied with UV-visible light and airacetylene burner.
Continuous data was subjected to a one-way analysis of variance followed by the post-hoc LSD analysis (26) . Non-parametric data (ranked or discontinuous) of the open-fi eld test was analysed by the Mann-Whitney-U-test (46). We used the Past Statistics Package (http://folk.uio.no/ohammer/past/ index.html) for the statistical analysis. The level of signifi cance was at P < 0.05.
RESULTS

LD 50 experiment
The acute (24- Table 1 ). The signs of poisoning appeared in the chicks within 2 min and 13 min after parenteral administration and within 20 min and 32 min after oral administration. The signs comprised drooping of the head, closing eyelids, ataxia, ruffl ed feathers, reduced motility or immotility and recumbency on the sternum regardless of the route of administration.
Open-fi eld activity and tonic immobility
The three-minute open-fi eld activity patterns and tonic immobility performance of chicks treated with Mn at (5, 10 and 20) mg kg -1 i.m. are shown in Table  2 . Generally, Mn did not produce overt signs of Table 2) . Manganese also increased the duration of the chicks' tonic immobility response compared with that of the control group (Table 2) .
Pharmacological challenges
Pre-treatment of chicks with Mn at 10 mg kg -1 i.m. signifi cantly reduced the time needed for the onset of righting refl ex loss induced by both xylazine-ketamine and thiopental anaesthetics when compared with the respective saline-control group (Table 3) . Manganese treatment significantly prolonged the duration of righting reflex loss of thiopental but not that of xylazine-ketamine (Table 3) .
Chlorpromazine challenge of Mn-treated chicks signifi cantly increased the depressant action of Mn in the open-fi eld arena as manifested by the immobility, reduced escape jumps, reduced defecation scores and reduced number of distress calls (Table 4) . Furthermore, chlorpromazine increased the time during which the chicks remained immobile in the tonic immobility test as a result of Mn treatment (Table 4) . These changes occurred in spite of the apparently non-depressant action of chlorpromazine at the dosage used (5 mg kg -1 ) ( Table 4) .
Manganese contents in the plasma and tissues
The injections of Mn at (10, 20, 50 and 100) mg kg -1 , i.m. signifi cantly elevated Mn contents in the plasma, entire brain, liver and kidney of the chicks in a manner dependant on the dose of the metal ( Figure  1 ).
DISCUSSION
The LD 50 values of Mn injected i.p., s.c. and i.m. or dosed orally are the fi rst report of an acute toxicity of this metal in seven-day-old chicks. Comparatively, the reported LD 50 values of Mn administered as MnCl 2 in mice and rats were 53 mg kg -1 and 38 mg kg -1 , i.p., respectively (27) and 450 mg kg -1 and (410 to 475) mg kg -1 when dosed orally, respectively (27) . Expectedly, the oral dosage form of Mn exerts a lesser toxicity than the parenteral ones because of the differences in the absorption rate and distribution between the routes of administration (27) (28) (29) . However, all discrepancies in the LD 50 values of Mn between rodents and chicks could be attributed to species variation and their physiological inputs into metal bioavailability (29) . The toxic signs in the chicks during the LD 50 experiments were characterized by depressive effects before recumbency. According to the LD 50 values of Mn in chicks, the metal can be categorized as highly toxic when given parenterally (30), although we do not intend to claim direct extrapolation from the avian species to mammals.
The acute single dose administration of Mn at (5 to 20) mg kg -1 i.m. produced a behavioural pattern in the open-fi eld test characterized by reduced general locomotor activity. The tonic immobility test further suggested the depressant action of Mn in chicks. These effects suggest the depressant action of the metal on the brain (31, 32) . Limited information is available on the toxicological profi le of Mn in the avian species. However, acute Mn administration at 40 mg kg -1 s.c. reduced jumping behaviour and increased the duration of tonic immobility in one-month-old chickens (6). Our results are in agreement with the reports describing Mn as a depressant in rodents according to locomotor activity measures (2, 4) . It is well-known that drugs that depress brain activities decrease general locomotion of chicks and rodents in the open-fi eld behavioural paradigm, whereas stimulants increase it (31) (32) (33) (34) . The open-fi eld activity and tonic immobility tests are robust observational behavioural tools that detect initial behavioural anomalies in the test animal (23, 31, 35) . During these tests, the experimental animal must cope with a strange environment in a manner that refl ects the overall activity status of the brain (31, 35) . Furthermore, the changes in the behavioural patterns of Mn-treated chicks from the Challenging Mn-treated chicks with central nervous system (CNS) active drugs revealed the sensitivity of the birds to general anaesthetics (xylazine-ketamine and thiopental). This was revealed by the decreases in the latencies of the onset of righting refl ex loss and the prolongation of the duration of thiopental sleep time. Our fi ndings further support a previous report of Mn enhancing the anaesthetic effect of xylazine-ketamine (increased durations of analgesia and sleep time) in chickens (6) . Manganese also enhances ethanol-induced sleep in mice and rats (36) . Another pharmacological challenge in the present study was using the tranquilizer chlorpromazine. The unique feature of chlorpromazine as a successful pharmacological challenge might be related to its antidopaminergic action as a phenthioazine tranquilizer (37) , which was presumed to modulate the Mninduced behavioural changes. Indeed, this was the case; chlorpromazine increased the depressant action of Mn in the open-fi eld and increased the duration of the tonic immobility response of Mn in the chicks. Manganese modulates catecholamine levels and turnover in the brain by decreasing dopamine and increasing homovanilic acid levels (11) . Dopaminergic activity in the CNS of the chicks has been said to control general locomotor activity (38) as well as modulate vigilance-related behaviours such as pecking and vocalization (39) . Pharmacological challenges in the form of depressant or stimulant drugs are used to reveal rather subtle effects of toxic agents affecting the CNS (6, 32, 33) .
The neurochemical and neurobehavioural changes induced by Mn might be associated with the accumulation of the metal in different regions of the brain (18, 19, 28) . Manganese accumulates in brain regions rich in dopamine (40) . In support of this claim, Mn levels increased in the entire brain 1.25 to 4 times following i.m. administration at doses of (10 to 100) mg kg -1 ( Figure 1 ). It is also speculated that the differential Mn distribution in brain tissues might contribute to different behavioural outcomes (18, 19, 28) . Further, the doses of Mn used in the present study were lower than those used in rats [ (25, 50 (tonic immobility test) . Mangan je smanjio ukupnu lokomotornu aktivnost pilića u areni otvorenog polja, što je bilo vidljivo iz značajnog povećanja sklonosti kretanju od središnjeg kvadrata i smanjenju broja prelazaka linije, frekvencije defekacije i rezultata vokalizacije u usporedbi s kontrolnim vrijednostima. Također je djelovao na produljenje odgovora pilića na test tonične nepomičnosti. Farmakološki pripravci kao što su opći anestetici ksilazin, ketamin i tiopental davani su pilićima nakon mangana te su uzrokovali gubitak posturalnih refl eksa unutar kraćeg vremena od kontrolnih vrijednosti. Tiopental je produljio trajanje gubitka posturalnih refleksa u usporedbi s kontrolnom skupinom. Klorpromazin je značajno povećao depresivnu aktivnost mangana u pilića ispitanih testom otvorenoga polja, kao i trajanje odgovora na test tonične nepomičnosti izazvanog manganom. Doze mangana od 10 mg kg -1 , 20 mg kg -1 , 50 mg kg -1 i 100 mg kg -1 dane intramuskularno značajno su povećale razine mangana u plazmi, jetrima, bubrezima i cijelome mozgu pilića. Podaci upućuju na akutnu neurotoksičnost manganova klorida kod mladih pilića, očitovanu kao depresivna aktivnost koja se može odrediti testovima otvorenog polja i tonične nepomičnosti uz potporu farmakoloških dodataka. 
